The JOHNSON'S brand, known for iconic products like baby shampoos and lotions , is owned by Kenvue Inc.. Kenvue is a standalone, publicly traded company that was spun off from Johnson & Johnson in August 2023. Detailed Company Description of Kenvue Overview: Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. It focuses exclusively on everyday care products, distinct from Johnson & Johnson's current focus on pharmaceuticals and medical technology. Headquarters: The company is headquartered in Summit, New Jersey, United States. Purpose and Philosophy: Kenvue's stated purpose is to "Realize the Extraordinary Power of Everyday Care". The company operates on the belief that everyday self-care rituals contribute significantly to overall well-being. Brand Portfolio: In addition to the JOHNSON'S baby line, Kenvue's extensive portfolio of science-backed brands includes: Pain Management: Tylenol (acetaminophen) Skin Health & Beauty: Neutrogena, Aveeno Oral Care: Listerine Wound Care: BAND-AID Brand Adhesive Bandages Other: Benadryl, Zyrtec Market Position and Operations: Kenvue operates globally, touching the lives of over a billion consumers worldwide. It employs approximately 22,000 people and competes in the consumer packaged goods industry. The company operates with a strong emphasis on scientific research and professional recommendations for its products. Recent Developments Acquisition: In November 2025, Kimberly-Clark announced its intent to acquire Kenvue, a deal expected to close in the second half of 2026, which would further expand its portfolio of consumer brands. Product Formulation: The company has transitioned its baby powder products from talc-based formulas to cornstarch-based ones globally, a commercial decision made amid ongoing litigation and changing consumer sentiment regarding talc safety.